Johnson & Johnson starts phase three trial testing of COVID-19 vaccine candidate

존슨앤드존슨, 코로나 백신 3상 임상시험 착수…미국서 4번째 American drugmaker Johnson and Johnson has begun its phase three trial of its COVID-19 vaccine candidate. Johnson and Johnson is now the fourth drugmaker backed by the Trump administration to enter late-stage testing after Moderna, Pfizer and AstraZeneca. Johnson and Johnson's trial will enroll up to 60-thousand adult volunteers across 215 locations in the U.S. and other countries. The company expects possible vaccine batches for potential emergency use authorization to be available early next year. 2020-09-24, 07:00 (KST) #Johnson&Johnson #COVID19 #vaccine 📣 Arirang News(Facebook) :   / arirangtvnews   📣 Arirang News(Twitter) :   / arirangtvnews   📣 News Center(YouTube) :    / newscenter_arirangtv